ArticleInternational journal of women's health2026
Postpartum Cardiometabolic Screening and Recorded Nursing-Process Indicators After Gestational Diabetes and Hypertensive Disorders of Pregnancy: An Institutional Retrospective Cohort Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gestational diabetes mellitus (GDM) and hypertensive disorders of pregnancy (HDP) mark elevated postpartum cardiometabolic risk, but less is known about how recorded nursing-process indicators relate to screening completion within institutional postpartum follow-up pathways. Methods: This single-center retrospective cohort used an institutional postpartum follow-up analytic cohort from Zibo Central Hospital. Records of women delivered from January 1, 2021 to December 31, 2025 were reviewed through 84 days postpartum, and inclusion required sufficient follow-up, clinical covariate, nursing-process, and screening-completion information. The primary outcome was completion of an institutional cardiometabolic screening package comprising recorded postpartum blood pressure, postpartum BMI, glucose-related testing, and lipid profile. Modified Poisson regression estimated risk ratios (RRs) with sequential adjustment for delivery year, clinical covariates, and recorded nursing contact score. Results: Of 1286 candidate records, 800 women were included: 376 controls, 214 GDM only, 139 HDP only, and 71 coexisting GDM/HDP. Screening completion was 63.8%, 77.1%, 77.0%, and 88.7%, respectively. After delivery-year and clinical adjustment, GDM only (RR 1.18, 95% CI 1.05-1.33), HDP only (RR 1.18, 95% CI 1.03-1.35), and coexisting GDM/HDP (RR 1.37, 95% CI 1.20-1.57) had higher screening completion than controls. After adding nursing contact score, group associations attenuated; nursing contact score remained associated with screening completion (RR 1.11 per point, 95% CI 1.06-1.17). Among screened women, coexisting GDM/HDP showed the highest abnormal blood pressure, abnormal glucose, and BMI ≥30.0 kg/m2 rates. Conclusion: Women with coexisting GDM/HDP had the highest documented screening completion and substantial observed cardiometabolic abnormality among screened records. Recorded nursing-process indicators were associated with screening completion within this selected institutional cohort, supporting pathway-level interpretation rather than causal intervention claims.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.